Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-48.10	24.94	48.05
Graham Fair Price	3.03	1774.82	1722.69
PEG	-20.04	-0.03	0.04
Price/Book	-6.72	0.45	0.48
Price/Cash Flow	31.92	-8.39	6.36
Prices/Earnings	-10.77	6.90	-7.73
Price/Sales	-17.82	0.46	0.56
Price/FCF	31.92	-8.39	6.36
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.36	0.28	0.30
Operating Margin	140.10	0.04	0.02
ROA	-1.78	< 0.005	< 0.005
ROE	-0.02	0.02	4.54
ROIC	< 0.005	0.01	75.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.13	-0.06	132.29
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.52	1.75	235.93
EPS QOQ	-1.84	2.05	11.59
FCF QOQ	2.47	-1.71	-30.80
Revenue QOQ	-0.19	0.14	-24.91
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	127.55	109.71	-13.99
Days Sales Outstanding (DSO)	52.32	55.19	5.49
Inventory Turnover	0.71	0.82	16.26
Debt/Capitalization	0.49	0.52	5.78
Quick Ratio	0.62	0.64	4.21
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2917.61	2939.87	0.76
Cash	341.24	450.57	32.04
Capex	-120.92	-71.58	40.80
Free Cash Flow	219.94	-156.70	-28.75
Revenue	2506.36	2866.67	14.38
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.54	1.41	-8.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	31.12	17.04	-45.25
Naive Interpretation	Member

06 - Financial Health · Weak

Rating